Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy

被引:620
|
作者
Ommen, SR
Maron, BJ
Olivotto, I
Maron, MS
Cecchi, F
Betocchi, S
Gersh, BJ
Ackerman, MJ
McCully, RB
Dearani, JA
Schaff, HV
Danielson, GK
Tajik, AJ
Nishimura, RA
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN USA
[3] Azienda Osped Careggi, Reg Referal Ctr Myocardial Dis, Florence, Italy
[4] Tufts Univ, New England Med Ctr, Hypertroph Cardiomyopathy Ctr, Div Cardiol, Boston, MA 02111 USA
[5] Univ Naples Federico II, Dept Clin Med Cardiovasc & Immunol Sci, Naples, Italy
关键词
D O I
10.1016/j.jacc.2005.02.090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to determine the impact of surgical myectomy on long-term survival in hypertrophic cardiomyopathy (HCM). BACKGROUND Left ventricular (LV) outflow tract obstruction in HCM increases the likelihood of heart failure and cardiovascular death. Although surgical myectomy is the primary treatment for amelioration of outflow obstruction and advanced drug-refractory heart failure symptoms, its impact on long-term survival remains unresolved. METHODS Total and HCM-related mortality were compared in three subgroups comprised of 1,337 consecutive HCM patients evaluated from 1983 to 2001: 1) surgical myectomy (n = 289); 2) LV outflow obstruction without operation (n = 228), and 3) nonobstructive (n = 820). Mean follow-up duration was 6 6 years. RESULTS Including two operative deaths (procedural mortality, 0.8%), 1-, 5-, and 10-year overall survival after myectomy was 98%, 96%, and 83%, respectively, and did not differ from that of the general U.S. population matched for age and gender (p = 0.2) nor from patients with nonobstructive HCM (p = 0.8). Compared to nonoperated obstructive HCM patients, myectomy patients experienced superior survival free from all-cause mortality (98%, 96%, and 83% vs. 90%, 79%, and 61%, respectively, p < 0.001), HCM-related mortality (99%, 98%, and 95% vs. 94%, 89%, and 73%, respectively, p < 0.001), and sudden cardiac death (100%, 99%, and 99% vs. 97%, 93%, and 89%, respectively, p = 0.003). Multivariate analysis showed myectomy to have a strong, independent association with survival (hazard ratio 0.43; p < 0.001). CONCLUSIONS Surgical myectomy performed to relieve outflow obstruction and severe symptoms in HCM was associated with long-term survival equivalent to that of the general population, and superior to obstructive HCM without operation. In this retrospective study, septal myectomy seems to reduce mortality risk in severely symptomatic patients with obstructive HCM.
引用
收藏
页码:470 / 476
页数:7
相关论文
共 50 条
  • [1] Effects of surgical septal myectomy on survival in patients with hypertrophic obstructive cardiomyopathy
    Meng, Xiangbin
    Liang, Mingyu
    Shi, Yong-en
    Zhang, Weijie
    Zhou, Sijie
    Gao, Chuanyu
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2020, 23 (06): : 342 - 348
  • [2] The long-term effect of surgical myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
    Ommen, SR
    Olivotto, L
    Maron, MS
    Betocchi, S
    Cecchi, F
    Ackerman, MJ
    Gersh, BJ
    Dearani, JA
    Schaff, HV
    Nishimura, RA
    Maron, BJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 215A - 215A
  • [3] Can surgical septal myectomy improve survival in patients with obstructive hypertrophic cardiomyopathy?
    Magdi H Yacoub
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 : 616 - 617
  • [4] Can surgical septal myectomy improve survival in patients with obstructive hypertrophic cardiomyopathy?
    Yacoub, MH
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2005, 2 (12): : 616 - 617
  • [5] Clinical long-term outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in infants
    Schleihauf, Julia
    Cleuziou, Julie
    von Ohain, Jelena Pabst
    Meierhofer, Christian
    Stern, Heiko
    Shehu, Nerejda
    Mkrtchyan, Naira
    Kaltenecker, Emanuel
    Kuehn, Andreas
    Nagdyman, Nicole
    Hager, Alfred
    Seidel, Heide
    Lange, Ruediger
    Ewert, Peter
    Wolf, Cordula M.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 53 (03) : 538 - 544
  • [6] Conduction Abnormalities and Long-Term Mortality Following Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy
    Cui, Hao
    Schaff, Hartzell, V
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Dearani, Joseph A.
    Lahr, Brian D.
    Ommen, Steve R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (05) : 645 - 655
  • [7] Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy
    Woo, A
    Williams, WG
    Choi, R
    Wigle, ED
    Rozenblyum, E
    Fedwick, K
    Siu, S
    Ralph-Edwards, A
    Rakowski, H
    CIRCULATION, 2005, 111 (16) : 2033 - 2041
  • [8] The Long-Term Outcomes of Transcoronary Ablation of Septal Hypertrophy Compared to Surgical Myectomy in Patients with Symptomatic Hypertrophic Obstructive Cardiomyopathy
    Samardhi, Himabindu
    Walters, Darren L.
    Raffel, Christopher
    Rateesh, Shruti
    Harley, Catherine
    Burstow, Darryl
    Pohlner, Peter
    Aroney, Con
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 83 (02) : 270 - 277
  • [9] Predictors of long-term outcome after rescue surgical septal myectomy in hypertrophic obstructive cardiomyopathy patients with previous alcohol septal ablation
    Zhu, C.
    Wang, S.
    Song, Y.
    Yu, Q.
    Tang, B.
    Wang, S.
    Wu, R.
    EUROPEAN HEART JOURNAL, 2018, 39 : 727 - 727
  • [10] Long-term effects of septal myectomy on sudden cardiac death in patients with hypertrophic cardiomyopathy
    Shapieva, A.
    Dzemeshkevich, S.
    Podolyak, D.
    Tsyganov, A.
    EUROPEAN HEART JOURNAL, 2016, 37 : 90 - 90